Trial Outcomes & Findings for Light Therapy as Treatment for Fatigue in Multiple Sclerosis (NCT NCT03060759)

NCT ID: NCT03060759

Last Updated: 2020-05-13

Results Overview

Measure of general level of fatigue. Range: 9 to 63. Lower scores indicate less reported fatigue.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

35 participants

Primary outcome timeframe

4 weeks

Results posted on

2020-05-13

Participant Flow

Participant milestones

Participant milestones
Measure
Light Therapy-Spectrum 1
Light from 'active' spectrum Light Therapy box: The light box used for LT (SunRay by The Sunbox Company, Gaithersburg, Maryland, USA) is approximately 15.5" tall x 23" wide x 3.25" deep and is designed to stand on a desk or tabletop. It can be used both in the home or office. The light is delivered at a downward angle to maximize the effectiveness. The box runs on 124 watts and contains full spectrum 5000k 10,000 lux bulbs.
Light Therapy-Spectrum 2
Light from 'placebo' spectrum Light Therapy box: The light box used for LT (SunRay by The Sunbox Company, Gaithersburg, Maryland, USA) is approximately 15.5" tall x 23" wide x 3.25" deep and is designed to stand on a desk or tabletop. It can be used both in the home or office. The light is delivered at a downward angle to maximize the effectiveness. The box runs on 124 watts and contains full spectrum 5000k 10,000 lux bulbs.
Overall Study
STARTED
20
15
Overall Study
COMPLETED
15
12
Overall Study
NOT COMPLETED
5
3

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Row population is equal to overall population.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Light Therapy-Spectrum 1
n=20 Participants
Light from 'active' spectrum Light Therapy box: The light box used for LT (SunRay by The Sunbox Company, Gaithersburg, Maryland, USA) is approximately 15.5" tall x 23" wide x 3.25" deep and is designed to stand on a desk or tabletop. It can be used both in the home or office. The light is delivered at a downward angle to maximize the effectiveness. The box runs on 124 watts and contains full spectrum 5000k 10,000 lux bulbs.
Light Therapy-Spectrum 2
n=15 Participants
Light from 'placebo' spectrum Light Therapy box: The light box used for LT (SunRay by The Sunbox Company, Gaithersburg, Maryland, USA) is approximately 15.5" tall x 23" wide x 3.25" deep and is designed to stand on a desk or tabletop. It can be used both in the home or office. The light is delivered at a downward angle to maximize the effectiveness. The box runs on 124 watts and contains full spectrum 5000k 10,000 lux bulbs.
Total
n=35 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants • Row population is equal to overall population.
0 Participants
n=7 Participants • Row population is equal to overall population.
0 Participants
n=5 Participants • Row population is equal to overall population.
Age, Categorical
Between 18 and 65 years
20 Participants
n=5 Participants • Row population is equal to overall population.
15 Participants
n=7 Participants • Row population is equal to overall population.
35 Participants
n=5 Participants • Row population is equal to overall population.
Age, Categorical
>=65 years
0 Participants
n=5 Participants • Row population is equal to overall population.
0 Participants
n=7 Participants • Row population is equal to overall population.
0 Participants
n=5 Participants • Row population is equal to overall population.
Age, Continuous
47.2 years
n=5 Participants
41.9 years
n=7 Participants
44.9 years
n=5 Participants
Sex: Female, Male
Female
16 Participants
n=5 Participants
12 Participants
n=7 Participants
28 Participants
n=5 Participants
Sex: Female, Male
Male
4 Participants
n=5 Participants
3 Participants
n=7 Participants
7 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
3 Participants
n=7 Participants
4 Participants
n=5 Participants
Race (NIH/OMB)
White
18 Participants
n=5 Participants
10 Participants
n=7 Participants
28 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Region of Enrollment
United States
20 participants
n=5 Participants
15 participants
n=7 Participants
35 participants
n=5 Participants
Years since first diagnosis
12.39 years
n=5 Participants
8.93 years
n=7 Participants
10.9 years
n=5 Participants
Expanded Disability Status Scale Score
3.1 units on a scale
n=5 Participants
3.1 units on a scale
n=7 Participants
3.1 units on a scale
n=5 Participants
Type of Multiple Sclerosis
Relapsing-remitting MS
20 Participants
n=5 Participants
15 Participants
n=7 Participants
35 Participants
n=5 Participants
Type of Multiple Sclerosis
Primary Progressive MS
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 4 weeks

Population: 4 participants were withdrawn from the study before providing outcome data.

Measure of general level of fatigue. Range: 9 to 63. Lower scores indicate less reported fatigue.

Outcome measures

Outcome measures
Measure
Light Therapy-Spectrum 1
n=17 Participants
Light from 'active' spectrum Light Therapy box: The light box used for LT (SunRay by The Sunbox Company, Gaithersburg, Maryland, USA) is approximately 15.5" tall x 23" wide x 3.25" deep and is designed to stand on a desk or tabletop. It can be used both in the home or office. The light is delivered at a downward angle to maximize the effectiveness. The box runs on 124 watts and contains full spectrum 5000k 10,000 lux bulbs.
Light Therapy-Spectrum 2
n=14 Participants
Light from 'placebo' spectrum Light Therapy box: The light box used for LT (SunRay by The Sunbox Company, Gaithersburg, Maryland, USA) is approximately 15.5" tall x 23" wide x 3.25" deep and is designed to stand on a desk or tabletop. It can be used both in the home or office. The light is delivered at a downward angle to maximize the effectiveness. The box runs on 124 watts and contains full spectrum 5000k 10,000 lux bulbs.
Change in Average Fatigue Severity Scale (FSS) Score
45.824 score on a scale
Standard Deviation 11.8
46.714 score on a scale
Standard Deviation 10.2

Adverse Events

Light Therapy-Spectrum 1

Serious events: 0 serious events
Other events: 15 other events
Deaths: 0 deaths

Light Therapy-Spectrum 2

Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Light Therapy-Spectrum 1
n=17 participants at risk
Light from 'active' spectrum Light Therapy box: The light box used for LT (SunRay by The Sunbox Company, Gaithersburg, Maryland, USA) is approximately 15.5" tall x 23" wide x 3.25" deep and is designed to stand on a desk or tabletop. It can be used both in the home or office. The light is delivered at a downward angle to maximize the effectiveness. The box runs on 124 watts and contains full spectrum 5000k 10,000 lux bulbs.
Light Therapy-Spectrum 2
n=14 participants at risk
Light from 'placebo' spectrum Light Therapy box: The light box used for LT (SunRay by The Sunbox Company, Gaithersburg, Maryland, USA) is approximately 15.5" tall x 23" wide x 3.25" deep and is designed to stand on a desk or tabletop. It can be used both in the home or office. The light is delivered at a downward angle to maximize the effectiveness. The box runs on 124 watts and contains full spectrum 5000k 10,000 lux bulbs.
Nervous system disorders
Headache
47.1%
8/17 • Adverse event data was collected over 4 weeks of light therapy, with collection at 2 and 4 weeks after starting light therapy.
4 participants were withdrawn from the study prior to collection of adverse event data.
7.1%
1/14 • Adverse event data was collected over 4 weeks of light therapy, with collection at 2 and 4 weeks after starting light therapy.
4 participants were withdrawn from the study prior to collection of adverse event data.
General disorders
Difficulty Sleeping
17.6%
3/17 • Adverse event data was collected over 4 weeks of light therapy, with collection at 2 and 4 weeks after starting light therapy.
4 participants were withdrawn from the study prior to collection of adverse event data.
0.00%
0/14 • Adverse event data was collected over 4 weeks of light therapy, with collection at 2 and 4 weeks after starting light therapy.
4 participants were withdrawn from the study prior to collection of adverse event data.
Eye disorders
Eye issues
5.9%
1/17 • Adverse event data was collected over 4 weeks of light therapy, with collection at 2 and 4 weeks after starting light therapy.
4 participants were withdrawn from the study prior to collection of adverse event data.
14.3%
2/14 • Adverse event data was collected over 4 weeks of light therapy, with collection at 2 and 4 weeks after starting light therapy.
4 participants were withdrawn from the study prior to collection of adverse event data.
General disorders
Dizziness
5.9%
1/17 • Adverse event data was collected over 4 weeks of light therapy, with collection at 2 and 4 weeks after starting light therapy.
4 participants were withdrawn from the study prior to collection of adverse event data.
0.00%
0/14 • Adverse event data was collected over 4 weeks of light therapy, with collection at 2 and 4 weeks after starting light therapy.
4 participants were withdrawn from the study prior to collection of adverse event data.
General disorders
Fatigue
5.9%
1/17 • Adverse event data was collected over 4 weeks of light therapy, with collection at 2 and 4 weeks after starting light therapy.
4 participants were withdrawn from the study prior to collection of adverse event data.
0.00%
0/14 • Adverse event data was collected over 4 weeks of light therapy, with collection at 2 and 4 weeks after starting light therapy.
4 participants were withdrawn from the study prior to collection of adverse event data.
General disorders
Hot flash
5.9%
1/17 • Adverse event data was collected over 4 weeks of light therapy, with collection at 2 and 4 weeks after starting light therapy.
4 participants were withdrawn from the study prior to collection of adverse event data.
0.00%
0/14 • Adverse event data was collected over 4 weeks of light therapy, with collection at 2 and 4 weeks after starting light therapy.
4 participants were withdrawn from the study prior to collection of adverse event data.

Additional Information

Farrah J. Mateen, MD, PhD, Associate Professor of Neurology

Massachusetts General Hospital

Phone: 617-724-8653

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place